The National Security Commission on Emerging Biotechnology (
As the former director of the Center for Biologics Evaluatio
Halia Therapeutics CEO David Bearss, PhD, Mark Ott, MD, dean
Michelle Holyoak and Jacey Skinner discussed several topics
Dr. Michelle Tarver, Director of the Center for Devices and
Carter Dredge, PhD, Bus.D, executive director, Intermountain